FarFaR - Pharmacy Repository
University of Belgrade, Faculty of Pharmacy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study

Thumbnail
2022
Quality_of_life_pub_2022.pdf (1.491Mb)
Authors
Doneva, Miglena
Milushewa, Petya
Dimitrova, Maria
Kamusheva, Maria
Stoitchkov, Jordan
Petrova, Guenka
Naydenova, Kremena
Krusheva, Borislava
Dimitrov, Vasil
Lakić, Dragana
Article (Published version)
Metadata
Show full item record
Abstract
This study aims to evaluate clinical characteristics, quality of life and control of treatment and therapy satisfaction of patients with asthma in Bulgaria. A pilot study of Bulgarian patients with asthma selected by allergologists was performed. The predefined inclusion criteria were asthma diagnosis with at least 6 months of living with asthma and use of asthma medication. Patient characteristics, treatment, quality-of-life, control of asthma and therapy satisfaction were systematically assessed. A retrospective observational study was conducted among asthma patients in Sofia in 2019. A strict definition of asthma-based solely on physicians’ diagnosis was used. Allergologists from two national reference hospitals for asthma therapy selected asthma patients. Every third patient with asthma that visited the office within 5 months period, and that agreed to participate was selected for the study. Quality-of-life of patients was measured using the EQ5D Assessment Test, control of asthma ...was assessed using ATCQ and ATC tests. A total of 71 asthma patients were enrolled. Approximately 43.6% were male, 16.9% were smokers, occupational risk factors were low (4.22%), 25% had moderate and 38% had severe asthma. The mean scores of asthma control treatment were 16.92 ± 5.68. The group has relatively high percentages of severe asthma patients. The asthma was not well controlled. National asthma strategies should focus on prevention and early detection of the disease.

Keywords:
Asthma control / quality of life of patients / satisfaction of treatment
Source:
Biotechnology and Biotechnological Equipment, 2022, 36, 1, 478-485
Publisher:
  • Taylor and Francis Ltd.

DOI: 10.1080/13102818.2022.2098818

ISSN: 1310-2818

WoS: 000827990700001

Scopus: 2-s2.0-85134371309
[ Google Scholar ]
URI
https://farfar.pharmacy.bg.ac.rs/handle/123456789/4202
Collections
  • Radovi istraživača / Researchers’ publications
Institution/Community
Pharmacy
TY  - JOUR
AU  - Doneva, Miglena
AU  - Milushewa, Petya
AU  - Dimitrova, Maria
AU  - Kamusheva,  Maria
AU  - Stoitchkov, Jordan
AU  - Petrova, Guenka
AU  - Naydenova, Kremena
AU  - Krusheva, Borislava
AU  - Dimitrov, Vasil
AU  - Lakić, Dragana
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4202
AB  - This study aims to evaluate clinical characteristics, quality of life and control of treatment and therapy satisfaction of patients with asthma in Bulgaria. A pilot study of Bulgarian patients with asthma selected by allergologists was performed. The predefined inclusion criteria were asthma diagnosis with at least 6 months of living with asthma and use of asthma medication. Patient characteristics, treatment, quality-of-life, control of asthma and therapy satisfaction were systematically assessed. A retrospective observational study was conducted among asthma patients in Sofia in 2019. A strict definition of asthma-based solely on physicians’ diagnosis was used. Allergologists from two national reference hospitals for asthma therapy selected asthma patients. Every third patient with asthma that visited the office within 5 months period, and that agreed to participate was selected for the study. Quality-of-life of patients was measured using the EQ5D Assessment Test, control of asthma was assessed using ATCQ and ATC tests. A total of 71 asthma patients were enrolled. Approximately 43.6% were male, 16.9% were smokers, occupational risk factors were low (4.22%), 25% had moderate and 38% had severe asthma. The mean scores of asthma control treatment were 16.92 ± 5.68. The group has relatively high percentages of severe asthma patients. The asthma was not well controlled. National asthma strategies should focus on prevention and early detection of the disease.
PB  - Taylor and Francis Ltd.
T2  - Biotechnology and Biotechnological Equipment
T1  - Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study
VL  - 36
IS  - 1
SP  - 478
EP  - 485
DO  - 10.1080/13102818.2022.2098818
ER  - 
@article{
author = "Doneva, Miglena and Milushewa, Petya and Dimitrova, Maria and Kamusheva,  Maria and Stoitchkov, Jordan and Petrova, Guenka and Naydenova, Kremena and Krusheva, Borislava and Dimitrov, Vasil and Lakić, Dragana",
year = "2022",
abstract = "This study aims to evaluate clinical characteristics, quality of life and control of treatment and therapy satisfaction of patients with asthma in Bulgaria. A pilot study of Bulgarian patients with asthma selected by allergologists was performed. The predefined inclusion criteria were asthma diagnosis with at least 6 months of living with asthma and use of asthma medication. Patient characteristics, treatment, quality-of-life, control of asthma and therapy satisfaction were systematically assessed. A retrospective observational study was conducted among asthma patients in Sofia in 2019. A strict definition of asthma-based solely on physicians’ diagnosis was used. Allergologists from two national reference hospitals for asthma therapy selected asthma patients. Every third patient with asthma that visited the office within 5 months period, and that agreed to participate was selected for the study. Quality-of-life of patients was measured using the EQ5D Assessment Test, control of asthma was assessed using ATCQ and ATC tests. A total of 71 asthma patients were enrolled. Approximately 43.6% were male, 16.9% were smokers, occupational risk factors were low (4.22%), 25% had moderate and 38% had severe asthma. The mean scores of asthma control treatment were 16.92 ± 5.68. The group has relatively high percentages of severe asthma patients. The asthma was not well controlled. National asthma strategies should focus on prevention and early detection of the disease.",
publisher = "Taylor and Francis Ltd.",
journal = "Biotechnology and Biotechnological Equipment",
title = "Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study",
volume = "36",
number = "1",
pages = "478-485",
doi = "10.1080/13102818.2022.2098818"
}
Doneva, M., Milushewa, P., Dimitrova, M., Kamusheva, M., Stoitchkov, J., Petrova, G., Naydenova, K., Krusheva, B., Dimitrov, V.,& Lakić, D.. (2022). Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study. in Biotechnology and Biotechnological Equipment
Taylor and Francis Ltd.., 36(1), 478-485.
https://doi.org/10.1080/13102818.2022.2098818
Doneva M, Milushewa P, Dimitrova M, Kamusheva M, Stoitchkov J, Petrova G, Naydenova K, Krusheva B, Dimitrov V, Lakić D. Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study. in Biotechnology and Biotechnological Equipment. 2022;36(1):478-485.
doi:10.1080/13102818.2022.2098818 .
Doneva, Miglena, Milushewa, Petya, Dimitrova, Maria, Kamusheva,  Maria, Stoitchkov, Jordan, Petrova, Guenka, Naydenova, Kremena, Krusheva, Borislava, Dimitrov, Vasil, Lakić, Dragana, "Quality of life, control of treatment and satisfaction of patients with asthma in Bulgaria: a pilot study" in Biotechnology and Biotechnological Equipment, 36, no. 1 (2022):478-485,
https://doi.org/10.1080/13102818.2022.2098818 . .

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB